BioCentury | Aug 12, 2013
Finance

Abiding no more

...APX004 , an anti-VEGF receptor 2 ( KDR/Flk-1 ; VEGFR-2 ) mAb, is licensed to Gansu Duyiwei Biotechnology Co. Ltd....
BioCentury | Mar 12, 2012
Company News

Apexigen Inc., Gansu Duyiwei deal

...Apexigen granted Gansu Duyiwei's Shanghai Duyiwei Biotechnology Co. Ltd. subsidiary an exclusive license to develop and commercialize...
...is eligible for milestones and royalties. Terms were not disclosed. Apexigen Inc. , Burlingame, Calif. Gansu Duyiwei Biotechnology Co. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Aug 12, 2013
Finance

Abiding no more

...APX004 , an anti-VEGF receptor 2 ( KDR/Flk-1 ; VEGFR-2 ) mAb, is licensed to Gansu Duyiwei Biotechnology Co. Ltd....
BioCentury | Mar 12, 2012
Company News

Apexigen Inc., Gansu Duyiwei deal

...Apexigen granted Gansu Duyiwei's Shanghai Duyiwei Biotechnology Co. Ltd. subsidiary an exclusive license to develop and commercialize...
...is eligible for milestones and royalties. Terms were not disclosed. Apexigen Inc. , Burlingame, Calif. Gansu Duyiwei Biotechnology Co. Ltd....
Items per page:
1 - 2 of 2